ORIC Pharmaceuticals, Inc., a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, announced three poster presentations and one oral presentation at the 2022 American Association for Cancer Research Annual Meeting taking place April 8-13, 2022, in New Orleans, LA.
March 8, 2022
· 8 min read